发明名称 |
Recombinant Human Albumin-Human Granulocyte Colony Stimulating Factor for the Prevention of Neutropenia |
摘要 |
Disclosed are compositions and methods for treating, preventing and ameliorating conditions and diseases characterized by a lowered white blood cell count. The methods and compositions described herein include a fusion polypeptide formed from human serum albumin protein (“HSA”) and human granulocyte-colony stimulating factor (“G-CSF”). |
申请公布号 |
US2015202268(A1) |
申请公布日期 |
2015.07.23 |
申请号 |
US201414574553 |
申请日期 |
2014.12.18 |
申请人 |
TEVA PHARMACEUTICAL INDUSTRIES LTD. |
发明人 |
BOCK Jason Benjamin;BELL Adam Carr;HERPST Jeffery |
分类号 |
A61K38/38;A61K38/19 |
主分类号 |
A61K38/38 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method of treating or preventing neutropenia in a human subject comprising administering to a human subject exhibiting neutropenia or at risk of developing neutropenia, recombinant human albumin-human granulocyte colony stimulating factor in an amount effective to treat the subject. |
地址 |
Petach Tikva IL |